This group will discuss topics related to the implementation and advances on continuous manufacturing of oral solid dose pharmaceutical products, including their advantages and disadvantages with respect to the more traditional batch process.
This group will discuss topics related to the actual implementation and advances on continuous manufacturing of Active Pharmaceutical Ingredients (APIs), including their advantages and disadvantages with respect to the batch process.
This group will discuss topics related to the implementation of traditional and new Process Analytical Tools (PAT) in continuous manufacturing of Active Pharmaceutical Ingredients (APIs) and Oral Solid Dose products.
This group explores the digital transformation of continuous manufacturing processes for drug substance and drug product. It serves as a collaborative space for professionals interested in process modeling, control strategies, and data analytics.
This group will discuss topics related to the actual implementation and regulatory implications of the continuous manufacturing of Active Pharmaceutical Ingredients (APIs) and Oral Solid Dose products.
Last Activity:
5 members
Have a general question about pharmaceutical continuous manufacturing? Post here to tap into the collective knowledge of our community.